ES497589A0 - Procedimiento para la preparacion de derivados 9cloro-pros- tanoicos - Google Patents

Procedimiento para la preparacion de derivados 9cloro-pros- tanoicos

Info

Publication number
ES497589A0
ES497589A0 ES497589A ES497589A ES497589A0 ES 497589 A0 ES497589 A0 ES 497589A0 ES 497589 A ES497589 A ES 497589A ES 497589 A ES497589 A ES 497589A ES 497589 A0 ES497589 A0 ES 497589A0
Authority
ES
Spain
Prior art keywords
substituted
aryl
alpha
group
hydrocarbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES497589A
Other languages
English (en)
Spanish (es)
Other versions
ES8200336A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of ES497589A0 publication Critical patent/ES497589A0/es
Publication of ES8200336A1 publication Critical patent/ES8200336A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
ES497589A 1979-12-10 1980-12-10 Procedimiento para la preparacion de derivados 9cloro-pros- tanoicos Expired ES8200336A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792950027 DE2950027A1 (de) 1979-12-10 1979-12-10 9-chlor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
ES497589A0 true ES497589A0 (es) 1981-11-16
ES8200336A1 ES8200336A1 (es) 1981-11-16

Family

ID=6088285

Family Applications (1)

Application Number Title Priority Date Filing Date
ES497589A Expired ES8200336A1 (es) 1979-12-10 1980-12-10 Procedimiento para la preparacion de derivados 9cloro-pros- tanoicos

Country Status (14)

Country Link
US (2) US4444788A (en, 2012)
EP (1) EP0030377B1 (en, 2012)
JP (1) JPS5692860A (en, 2012)
AT (1) ATE6364T1 (en, 2012)
AU (1) AU543797B2 (en, 2012)
CA (1) CA1196327A (en, 2012)
CS (1) CS226419B2 (en, 2012)
DE (2) DE2950027A1 (en, 2012)
DK (2) DK153944C (en, 2012)
ES (1) ES8200336A1 (en, 2012)
HU (1) HU183263B (en, 2012)
IE (1) IE51212B1 (en, 2012)
IL (1) IL61669A (en, 2012)
SU (1) SU1026652A3 (en, 2012)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2950027A1 (de) * 1979-12-10 1981-06-11 Schering Ag Berlin Und Bergkamen, 1000 Berlin 9-chlor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
US5204371A (en) * 1979-12-10 1993-04-20 Schering Aktiengesellschaft Pharmaceutically active 9-chloroprostaglandins
DE3126924A1 (de) * 1981-07-03 1983-01-20 Schering Ag, 1000 Berlin Und 4619 Bergkamen 9-fluor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
DE3148743A1 (de) * 1981-12-04 1983-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen 9-brom-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3325175A1 (de) * 1983-07-08 1985-01-17 Schering AG, 1000 Berlin und 4709 Bergkamen 11-halogen-prostanderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3337450A1 (de) * 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
DE3347128A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 9-halogen-(delta)(pfeil hoch)2(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3414509A1 (de) * 1984-04-13 1985-10-24 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 9-halogen-prostaglandine
DE3504044A1 (de) * 1985-02-04 1986-08-07 Schering AG, Berlin und Bergkamen, 1000 Berlin 9-halogenprostaglandin-clathrate und ihre verwendung als arzneimittel
DE3510978A1 (de) * 1985-03-22 1986-09-25 Schering AG, Berlin und Bergkamen, 1000 Berlin Neue 9-halogenprostaglandine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
DE3724189A1 (de) * 1987-07-17 1989-01-26 Schering Ag 9-halogen-(z)-(delta)(pfeil hoch)4(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihrer verwendung als arzneimittel
WO1989000559A1 (en) * 1987-07-17 1989-01-26 Schering Aktiengesellschaft Berlin Und Bergkamen 9-halogen-(z)-prostaglandin derivatives, process for manufacturing them, and their use as drugs
AU624078B2 (en) * 1987-07-17 1992-06-04 Schering Aktiengesellschaft Berlin Und Bergkamen 9-halogen-(z)-prostaglandin derivatives, process for manufacturing them, and their use as drugs
DE3724190A1 (de) * 1987-07-17 1989-01-26 Schering Ag 9-halogen-3-oxa-(z)-(delta)(pfeil hoch)5(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US5891910A (en) * 1987-07-17 1999-04-06 Schering Aktiengesellschaft 9-halogen-(Z) prostaglandin derivatives, process for their production and their use as pharmaceutical agents
DE4036140A1 (de) * 1990-11-09 1992-05-14 Schering Ag 9-halogen-11ss-hydroxy-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0652211A1 (en) * 1992-07-24 1995-05-10 Taisho Pharmaceutical Co. Ltd Prostaglandin derivative
WO1994005631A1 (de) * 1992-08-31 1994-03-17 Schering Aktiengesellschaft 9-chlor-prostaglandin-ester und -amide und ihre verwendung für die herstellung von arzneimitteln
DE4229048A1 (de) * 1992-08-31 1994-03-03 Schering Ag Ester von 9-Chlor-Prostaglandinen, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
DE4229050A1 (de) * 1992-08-31 1994-03-03 Schering Ag Neue 9-Chlor-Prostaglandin-Ester und -amide
US5972991A (en) * 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
IT1257479B (it) * 1992-12-01 1996-01-25 Derivati prostaglandinici aventi effetti radioprotettivi
DE4330177A1 (de) * 1993-08-31 1995-03-02 Schering Ag Neue 9-Chlor-prostaglandin-derivate
US5721273A (en) 1993-12-15 1998-02-24 Alcon Laboratories, Inc. Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension
US5807892A (en) * 1994-09-30 1998-09-15 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
US6235780B1 (en) 1998-07-21 2001-05-22 Ono Pharmaceutical Co., Ltd. ω-cycloalkyl-prostaglandin E1 derivatives
PL1816121T3 (pl) * 2005-11-21 2008-08-29 Bayer Schering Pharma Ag Pochodne 9-chloro-15-deoksyprostaglandyny, sposób ich wytwarzania oraz ich zastosowanie jako leków
US7563924B2 (en) * 2005-11-21 2009-07-21 Schering Aktiengesellschaft 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2517773A1 (de) * 1975-04-18 1976-10-28 Schering Ag Neue 11-oxo-prostaglandin-derivate und verfahren zu ihrer herstellung
US4163016A (en) * 1977-07-05 1979-07-31 Hoffmann-La Roche Inc. 16-Substituted prostaglandins
US4192799A (en) * 1977-09-21 1980-03-11 The Upjohn Company Conjugates formed by reacting a prostaglandin mimic compound with a carrier molecule
DE2950027A1 (de) * 1979-12-10 1981-06-11 Schering Ag Berlin Und Bergkamen, 1000 Berlin 9-chlor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel

Also Published As

Publication number Publication date
IE51212B1 (en) 1986-11-12
AU6519080A (en) 1981-06-18
CA1196327A (en) 1985-11-05
JPS5692860A (en) 1981-07-27
DE3066726D1 (en) 1984-03-29
DK573687A (da) 1987-11-02
IL61669A (en) 1986-08-31
HU183263B (en) 1984-04-28
EP0030377B1 (de) 1984-02-22
DE2950027A1 (de) 1981-06-11
CS226419B2 (en) 1984-03-19
US5079259A (en) 1992-01-07
ATE6364T1 (de) 1984-03-15
JPS6224422B2 (en, 2012) 1987-05-28
SU1026652A3 (ru) 1983-06-30
US4444788A (en) 1984-04-24
DK573687D0 (da) 1987-11-02
DK153944C (da) 1989-02-20
IL61669A0 (en) 1981-01-30
EP0030377A1 (de) 1981-06-17
AU543797B2 (en) 1985-05-02
IE802572L (en) 1981-06-10
DK526080A (da) 1981-06-11
ES8200336A1 (es) 1981-11-16
DK153944B (da) 1988-09-26

Similar Documents

Publication Publication Date Title
ES497589A0 (es) Procedimiento para la preparacion de derivados 9cloro-pros- tanoicos
ES508124A0 (es) "procedimiento para la preparacion de derivados de carbaciclina".
NO159174C (no) Fluorerte kopolymerer, samt fremgangsmaate ved fremstilling derav.
PT72131B (en) Novel fluorinated copolymer and preparation thereof
DK123587A (da) Analogifremgangsmaade til fremstilling af 9-fluor-prostaglandinderivater
SE7604409L (sv) Nya prostaglandin-acetylenanaloger och sett att framstella desamma
SE8003815L (sv) Alkyl-ketohexopyranosid-derivat
SE7705423L (sv) Forfarande for framstellning av prostaglandinderivat
SE7906761L (sv) Klorambucilderivat
MX9203752A (es) Novedosos derivados de acido p-oxibenzoico y procedimiento para la preparacion de los mismos y su uso como medicamentos.
ES454086A1 (es) Procedimiento para la preparacion de n-(r-tetrahidrofurfu- ril)-noroximorfona y n-(s-tetrahidrofurfuril)-norosimorfona nuevas.
SE7706245L (sv) Forfarande for framstellning av prostacyklinderivat
DK146246C (da) Fremgangsmaade til fremstilling af 17alfa-hydroxy-etiocarboxylsyrer eller 17aalfa-hydroxy-d-homo-etiocarboxylsyrer
KR830007693A (ko) 7-아미노 세펨 화합물을 제조하는 개량방법
CH609682A5 (en) Process for the preparation of compounds analogous to prostaglandins
ES395599A1 (es) Procedimiento para la preparacion de nuevos acidos 3 - (3- acilamino-2,4,6-triyodo-fenoxi)-alcoxi) - 2 - alcohil - pro-pionicos, utilizables como componentes suministradores de sombra en agentes de contraste de rayos x.
PT74184B (fr) Procede de preparation de nouveaux derives steroides 3-ceto delta 4 ou delta 1, 4 substitues en position 7
ATE8259T1 (de) Neue prostacyclinderivate und ihre herstellung.
ATE60785T1 (de) Verfahren zur herstellung von estran-derivaten.
ES526898A0 (es) Procedimiento para la preparacion de nuevas 7 -aciltio-1 ,2 -metilen-3-oxo-17 -pregn-4-en-21,17-carbolactonas
ES395036A2 (es) Procedimiento para producir un compuesto opticamente acti- vo.
ES517915A0 (es) Procedimiento para la preparacion de derivados 9-bromo-prostanicos.
ES451289A1 (es) Un procedimiento para la preparacion de hornoesterprocedimiento para la preparacion de derivados de oides. benzofura-no.
GB1537199A (en) Intermediates in the preparation of sterols
ES480141A1 (es) Procedimiento para la preparacion de derivados 6-oxigenados-3, 20-dioxo-pregnano.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001